Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 13
2004 31
2005 48
2006 48
2007 64
2008 97
2009 67
2010 70
2011 92
2012 95
2013 74
2014 48
2015 67
2016 65
2017 52
2018 69
2019 63
2020 39
2021 32
2022 44
2023 42
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

1,096 results

Results by year

Filters applied: . Clear all
Page 1
Primary hyperparathyroidism.
Muñoz-Torres M, García-Martín A. Muñoz-Torres M, et al. Med Clin (Barc). 2018 Mar 23;150(6):226-232. doi: 10.1016/j.medcli.2017.07.020. Epub 2017 Oct 6. Med Clin (Barc). 2018. PMID: 28992983 Review. English, Spanish.
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
EVOLVE Trial Investigators; Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS. EVOLVE Trial Investigators, et al. N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121374 Free article. Clinical Trial.
Cinacalcet Hydrochloride.
Mostafa GAE, Al-Badr AA. Mostafa GAE, et al. Profiles Drug Subst Excip Relat Methodol. 2017;42:1-90. doi: 10.1016/bs.podrm.2017.02.001. Epub 2017 Apr 3. Profiles Drug Subst Excip Relat Methodol. 2017. PMID: 28431775
Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
Block GA, Bushinsky DA, Cheng S, Cunningham J, Dehmel B, Drueke TB, Ketteler M, Kewalramani R, Martin KJ, Moe SM, Patel UD, Silver J, Sun Y, Wang H, Chertow GM. Block GA, et al. JAMA. 2017 Jan 10;317(2):156-164. doi: 10.1001/jama.2016.19468. JAMA. 2017. PMID: 28097356 Free article. Clinical Trial.
Cinacalcet hydrochloride.
Barman Balfour JA, Scott LJ. Barman Balfour JA, et al. Drugs. 2005;65(2):271-81. doi: 10.2165/00003495-200565020-00007. Drugs. 2005. PMID: 15631545 Review.
Cinacalcet hydrochloride for the treatment of hyperparathyroidism.
Verheyen N, Pilz S, Eller K, Kienreich K, Fahrleitner-Pammer A, Pieske B, Ritz E, Tomaschitz A. Verheyen N, et al. Expert Opin Pharmacother. 2013 Apr;14(6):793-806. doi: 10.1517/14656566.2013.777041. Epub 2013 Mar 4. Expert Opin Pharmacother. 2013. PMID: 23452174 Review.
Cinacalcet: pharmacological and clinical aspects.
Messa P, Alfieri C, Brezzi B. Messa P, et al. Expert Opin Drug Metab Toxicol. 2008 Dec;4(12):1551-60. doi: 10.1517/17425250802587017. Expert Opin Drug Metab Toxicol. 2008. PMID: 19040330 Review.
Cinacalcet (sensipar).
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2004 Sep 27;46(1192):80. Med Lett Drugs Ther. 2004. PMID: 15452465 No abstract available.
1,096 results